GlycoMimetics Inc has a consensus price target of $8, established from looking at the 9 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Capital One, and HC Wainwright & Co. on March 27, 2024, December 22, 2023, and August 3, 2023. With an average price target of $9.33 between HC Wainwright & Co., Capital One, and HC Wainwright & Co., there's an implied 404.50% upside for GlycoMimetics Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/27/2024 | GLYC | Buy Now | GlycoMimetics | $1.85 | 332.43% | HC Wainwright & Co. | Edward White | $8 → $8 | Maintains | Buy | Get Alert |
12/22/2023 | GLYC | Buy Now | GlycoMimetics | $1.85 | 548.65% | Capital One | Zegbeh Jallah | → $12 | Initiates | → Overweight | Get Alert |
08/03/2023 | GLYC | Buy Now | GlycoMimetics | $1.85 | 332.43% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | Buy → Buy | Get Alert |
06/15/2023 | GLYC | Buy Now | GlycoMimetics | $1.85 | 332.43% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | → Buy | Get Alert |
05/04/2023 | GLYC | Buy Now | GlycoMimetics | $1.85 | 332.43% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | → Buy | Get Alert |
03/30/2023 | GLYC | Buy Now | GlycoMimetics | $1.85 | 332.43% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | → Buy | Get Alert |
02/16/2023 | GLYC | Buy Now | GlycoMimetics | $1.85 | 332.43% | HC Wainwright & Co. | Edward White | $13 → $8 | Maintains | Buy | Get Alert |
08/04/2022 | GLYC | Buy Now | GlycoMimetics | $1.85 | 602.7% | HC Wainwright & Co. | Edward White | $14 → $13 | Maintains | Buy | Get Alert |
11/12/2021 | GLYC | Buy Now | GlycoMimetics | $1.85 | 116.22% | Jefferies | Roger Song | — | Upgrade | Hold → Buy | Get Alert |
The latest price target for GlycoMimetics (NASDAQ: GLYC) was reported by HC Wainwright & Co. on March 27, 2024. The analyst firm set a price target for $8.00 expecting GLYC to rise to within 12 months (a possible 363.77% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for GlycoMimetics (NASDAQ: GLYC) was provided by HC Wainwright & Co., and GlycoMimetics maintained their buy rating.
The last upgrade for GlycoMimetics Inc happened on November 12, 2021 when Jefferies raised their price target to $4. Jefferies previously had a hold for GlycoMimetics Inc.
There is no last downgrade for GlycoMimetics.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GlycoMimetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GlycoMimetics was filed on March 27, 2024 so you should expect the next rating to be made available sometime around March 27, 2025.
While ratings are subjective and will change, the latest GlycoMimetics (GLYC) rating was a maintained with a price target of $8.00 to $8.00. The current price GlycoMimetics (GLYC) is trading at is $1.73, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.